Impact of Medical Emergency Team in Tampere University Hospital
This study is currently recruiting participants.
Verified October 2010 by Tampere University Hospital
Sponsor:
Tampere University Hospital
Information provided by:
Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT01214460
First received: July 5, 2010
Last updated: October 1, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients in general wards have abnormal physical values preceding in-hospital cardiac arrest or a transfer to intensive care unit (ICU). The purpose of Medical Emergency Team (MET)is to interfere early enough in deteriorating patient status to prevent adverse outcomes like cardiac arrest or transfer to intensive care unit. The aims of this study are to record and analyze the effects of both afferent and efferent limbs of MET activity in Finnish tertiary Hospital.
| Condition |
|---|
|
Sudden In-hospital Cardiac Arrest |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Impact of Medical Emergency Team on ICU Readmissions and Sudden Cardiac Arrests in Tampere University Hospital |
Resource links provided by NLM:
Further study details as provided by Tampere University Hospital:
Primary Outcome Measures:
- The number of patients medical emergency team is called to treat in TAUH [ Time Frame: One year ] [ Designated as safety issue: No ]We are going to analyze the number of MET calls and their impact on sudden cardiac arrests in TAUH. The time frame is 1st Jan 2010 -31st Dec 2010. It is known fact that well working MET team inside the hospital should decrease the sudden cardiac arrests.
- The number of sudden cardiac arrests in TAUH [ Time Frame: One year ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- The rates of ICU readmissions [ Time Frame: One year ] [ Designated as safety issue: No ]
- The rates of DNAR orders [ Time Frame: one year ] [ Designated as safety issue: No ]
- In-hospital mortality [ Time Frame: patients are followed until death ] [ Designated as safety issue: No ]
- Patient mortality after 6 mo of discharge [ Time Frame: Six mo ] [ Designated as safety issue: No ]The patients are followed 6 mo after hospital discharge which has happened in year 2010
| Estimated Enrollment: | 1000 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| All MET calls |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
All adult in-hospital patients with deteriorating vital signs or patients in risk in Tampere University Hospital
Criteria
Inclusion Criteria:
- 18 yrs or older
Exclusion Criteria:
- under 18 yrs
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01214460
Contacts
| Contact: Sanna Hoppu, MD, PhD | 358331164982 | sanna.hoppu@pshp.fi |
| Contact: Joonas Tirkkonen, MB | 358504002789 | joonas.tirkkonen@uta.fi |
Locations
| Finland | |
| Critical Care Medicine Research Group, Tampere University Hospital | Recruiting |
| Tampere, Pirkanmaa, Finland, 33521 | |
| Contact: Jyrki Tenhunen, MD, PhD 3583311611 jyrki.tenhunen@pshp.fi | |
Sponsors and Collaborators
Tampere University Hospital
Investigators
| Study Director: | Jyrki Tenhunen, MD, PhD | Critical Care Medicine Research Group |
| Principal Investigator: | Sanna Hoppu, MD, PhD | Critical Care Medicine Research Group |
| Principal Investigator: | Joonas Tirkkonen, MB | Critical Care Medicine Research Group |
More Information
No publications provided
| Responsible Party: | Sanna Hoppu, MD, PhD, Critical Care Medicine Research Group, Tampere University Hospital |
| ClinicalTrials.gov Identifier: | NCT01214460 History of Changes |
| Other Study ID Numbers: | R10111 |
| Study First Received: | July 5, 2010 |
| Last Updated: | October 1, 2010 |
| Health Authority: | Finland: Ethics Committee |
Keywords provided by Tampere University Hospital:
|
MET |
Additional relevant MeSH terms:
|
Emergencies Heart Arrest Death, Sudden, Cardiac Disease Attributes Pathologic Processes |
Heart Diseases Cardiovascular Diseases Death, Sudden Death |
ClinicalTrials.gov processed this record on May 23, 2013